FDA Drug Recalls

Recalls / Class II

Class IID-1415-2014

Product

Venlafaxine Hydrochloride Extended-Release Tablets, 150 mg, Rx only, Packaged in 30 Count and 90 Count Bottles. Distributed by: Caraco Pharmaceutical Laboratories, Ltd., 1150 Elijah McCoy Drive, Detroit, MI 48202; Manufactured at: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India. 30-Count Bottle NDC: 41616-758-83, 90-Count Bottle: NDC 41616-758-81.

Affected lot / code info
30 Count Bottle: Lot #: JKL5054A, Expiry: 08/2014; Lot #: JKM2305A, Expiry: 03/2015. 90 Count Bottle: Lot #: JKL5054B, Expiry: 08/2014; Lot #: JKM2305B, Expiry: 03/2015.

Why it was recalled

Failed Dissolution Specifications: Stability results found the product did not meet the drug dissolution specifications.

Recalling firm

Firm
Caraco Pharmaceutical Laboratories, Ltd.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1150 Elijah McCoy Dr, Detroit, Michigan 48202-3344

Distribution

Quantity
26,530 30-Count Bottles; 14,597 90-Count Bottles
Distribution pattern
Nationwide including Puerto Rico

Timeline

Recall initiated
2014-06-12
FDA classified
2014-07-02
Posted by FDA
2014-07-09
Terminated
2015-05-06
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1415-2014. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.